Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aurantii Fructus Immaturus Flavonoid Tablets vs domperidone in functional dyspepsia (phase III)
ChiCTR2400083076Phase 3Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Total Flavonoids of Fructus Aurantii Immaturus in functional dyspepsia (FD) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Disappearance rate of all four functional dyspepsia symptoms after 4 weeks of treatment. Started Apr 2024; status: completed.
02
Drugs
Total Flavonoids of Fructus Aurantii Immaturus
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2400083076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083076.